查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1869728

生物製程自动化市场规模、份额和趋势分析报告：按产品/服务、製程阶段、最终用途、地区和细分市场预测（2025-2033 年）

Bioprocess Automation Market Size, Share & Trends Analysis Report By Product & Services, By Process Stage, By End Use, By Region, And Segment Forecasts, 2025 - 2033
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10个工作天内

价格

生物製程自动化市场摘要

2024年全球生物过程自动化市场规模估计为77.6亿美元，预计2033年将达到224.1亿美元。

预计从 2025 年到 2033 年，该行业将以 12.67% 的复合年增长率增长，这主要得益于对生物製药的需求不断增长、人工智慧和机器人技术的进步，以及对监管合规性和效率的需求。

生物製药需求不断成长

生物製剂需求的不断增长是生物製程自动化产业最重要的驱动力之一。过去十年，由于单株抗体、疫苗、基因疗法和其他生物製剂在治疗包括癌症、自体免疫疾病和罕见遗传疾病在内的复杂疾病方面的有效性，其研发和应用呈爆炸式增长。为了确保这些生物製剂保持有效性和高品质，生产过程必须严格控制、扩充性且精准。传统的手动或半自动生产方法通常劳动密集、容易出错，且无法满足不断增长的市场需求，因此迫切需要全自动生物製程解决方案。

随着全球医疗保健系统越来越依赖生物学来开发新型疗法，生物製程自动化的需求预计将会成长，并已成为现代製药生产的重要组成部分。生物製程自动化使製造商能够在不影响品质的前提下优化生产流程、提高一致性并增加产量。透过整合机器人、人工智慧和先进的监控系统，生物製药公司可以以更低的变异性、更短的交货时间和更低的营运成本，大规模生产生物製药。

提高效率和降低成本的必要性

降低成本和提高效率的需求是生物製程自动化市场的主要驱动力。生物製药生产是一个复杂且资源密集的过程，通常需要高素质的员工、细緻的监管和严格的通讯协定遵循。人工或半自动化流程劳力密集且容易出现人为错误，可能导致批次失败、产品品质不稳定以及生产成本增加。透过实施自动化系统，企业可以提高生产效率，减少对人工的依赖，最大限度地减少错误，并确保各生产批次的结果更加一致可靠。

自动化能够提高生产效率、显着降低营运成本并提升可靠性。自动化生物製程系统可实现连续运行，最大限度地减少停机时间，优化资源利用，并加快生产週期，从而使製造商能够更有效地满足不断增长的市场需求。在医疗保健产业成本意识日益增强的今天，以低成本生产高品质生物製药的能力也有助于企业保持竞争力。因此，对成本效益和营运效率的需求持续推动全球对生物製程自动化技术的投资。

目录

第一章调查方法和范围

第二章执行摘要

第三章 市场变数、趋势与范围

  • 市场体系展望
    • 母市场展望
    • 附随市场展望
  • 市场趋势与展望
  • 市场动态
    • 市场驱动因素的影响分析
    • 市场限制因素的影响分析
  • 商业环境分析
    • PESTLE分析
    • 波特五力分析

第四章 产品与服务业务分析

  • 产品和服务细分仪表板
  • 全球生物过程自动化市场：产品与服务、差异分析
  • 全球生物製程自动化市场规模及趋势分析（按产品和服务划分，2021-2033 年）
  • 自动化耗材和配件
  • 流程自动化硬体
  • 软体和控制系统
  • 整合式承包解决方案
  • 服务与支援

第五章：流程阶段业务分析

  • 流程阶段细分仪表板
  • 全球生物过程自动化市场製程阶段及变异分析
  • 全球生物製程自动化市场规模及趋势分析（依製程阶段划分，2021-2033 年）
  • 上游
  • 下游
  • 製程开发和放大
  • 填充/包装自动化
  • 品管和流程自动化技术

第六章 最终用户业务分析

  • 最终用户细分仪表板
  • 全球生物过程自动化市场最终用途及变化分析
  • 全球生物製程自动化市场规模及趋势分析（依最终用途划分，2021-2033 年）
  • 製药和生物技术製造商
  • CDMO 和 CMO
  • 学术研究机构
  • 合约测试和分析实验室
  • 其他的

第七章 生物製程自动化市场：区域估算与趋势分析，依产品、产品与服务、最终用途、最终用途

  • 区域仪錶板
  • 市场规模、预测与趋势分析，2021-2033年
  • 北美洲
    • 2021-2033年北美生物製程自动化市场
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 欧洲生物过程自动化市场，2021-2033年
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • 亚太地区生物过程自动化市场，2021-2033年
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 泰国
    • 韩国
  • 拉丁美洲
    • 2021-2033年拉丁美洲生物过程自动化市场
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 2021-2033年中东及非洲生物製程自动化市场
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第八章 竞争情势

  • 公司分类
  • 策略规划
  • 企业市场分析，2024年
  • 公司简介
    • Thermo Fisher Scientific Inc.
    • Sartorius AG
    • Parker Hannifin Corp
    • Merck KGaA
    • Eppendorf SE
    • SIA Bioreactors.net
    • Senieer
    • Getinge
    • Repligen Corporation
Product Code: GVR-4-68040-764-1

Bioprocess Automation Market Summary

The global bioprocess automation market size was estimated at USD 7.76 billion in 2024 and is projected to reach USD 22.41 billion by 2033, growing at a CAGR of 12.67% from 2025 to 2033, driven by rising demand for biologics, advancements in AI and robotics, and the need for regulatory compliance and efficiency.

Rising Demand for Biologics

The rising demand for biologics is among the most significant drivers of the bioprocess automation industry. Over the past decade, there has been a sharp increase in the development and use of monoclonal antibodies, vaccines, gene therapies, and other biologic products due to their effectiveness in treating complex diseases, including cancer, autoimmune disorders, and rare genetic conditions. For these biologics to remain effective and to maintain high quality, manufacturing procedures must be extremely controlled, scalable, and precise. There is a significant need for fully automated bioprocess solutions because traditional manual or semi-automated production methods are frequently labor-intensive, prone to mistakes, and inadequate to meet the expanding market demand.

The need for bioprocess automation is anticipated to increase as the world's healthcare system depends more on biology for novel treatments, making it an essential part of contemporary pharmaceutical production. Automation in bioprocessing allows manufacturers to optimize production workflows, improve consistency, and increase throughput without compromising quality. Biopharmaceutical companies can produce larger biologics with reduced variability, faster turnaround times, and lower operational costs by integrating robotics, AI, and advanced monitoring systems.

Need for Efficiency and Cost Reduction

The need for cost and efficiency reduction largely drives the market for bioprocess automation. Manufacturing biopharmaceuticals is a complicated and resource-intensive process that frequently requires highly qualified staff, careful observation, and strict protocol adherence. Batch failures, inconsistent products, and higher production costs can result from labor-intensive, human error-prone manual or semi-automated processes. By implementing automated systems, businesses can increase productivity, decrease reliance on manual labor, and minimize errors, guaranteeing more consistent and dependable results across production batches.

Automation increases productivity, drastically reduces operating costs, and improves reliability. Manufacturers can more effectively meet growing market demand thanks to automated bioprocessing systems' ability to run continuously with little downtime, optimize resource usage, and speed up production cycles. In an increasingly cost-sensitive healthcare environment, the ability to produce high-quality biologics at a lower cost also helps businesses stay competitive. As a result, the need for cost-effectiveness and operational efficiency keeps driving global investments in bioprocess automation technologies.

Global Bioprocess Automation Market Report Segmentation

This report forecasts revenue growth and provides an analysis on the latest trends in each of the sub-segments from 2021 to 2033. For this report, Grand View Research has segmented the global bioprocess automation market report based on product & service, process stage, end use, and region:

  • Product & Service Outlook (Revenue, USD Million, 2021 - 2033)
  • Automation Consumables & Accessories
  • Process Automation Hardware
  • Software & Control Systems
  • Integrated & Turnkey Solutions
  • Services & Support
  • Process Stage Outlook (Revenue, USD Million, 2021 - 2033)
  • Upstream
  • Downstream
  • Process Development & Scale-up
  • Fill/Finish & Packaging automation
  • Quality Control & PAT
  • End Use Outlook (Revenue, USD Million, 2021 - 2033)
  • Pharmaceutical & biotech manufacturers
  • CDMOs & CMOs
  • Academic & research institutions
  • Contract testing & analytical labs
  • Others
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Australia
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East and Africa (MEA)
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
    • 1.2.1. Product & Services
    • 1.2.2. Process Stage
    • 1.2.3. End Use
  • 1.3. Information analysis
  • 1.4. Market formulation & data visualization
  • 1.5. Data validation & publishing
  • 1.6. Information Procurement
    • 1.6.1. Primary Research
  • 1.7. Information or Data Analysis
  • 1.8. Market Formulation & Validation
  • 1.9. Market Details
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Ancillary Market Outlook
  • 3.2. Market Trends and Outlook
  • 3.3. Market Dynamics
    • 3.3.1. Market Driver Impact Analysis
      • 3.3.1.1. Rising demand for biologics
      • 3.3.1.2. Need for efficiency and cost reduction
    • 3.3.2. Market Restraint Impact Analysis
      • 3.3.2.1. High Initial Investment Costs
      • 3.3.2.2. Regulatory and Compliance Challenges
  • 3.4. Business Environment Analysis
    • 3.4.1. PESTLE Analysis
    • 3.4.2. PORTER'S Five Forces Analysis

Chapter 4. Product & Services Business Analysis

  • 4.1. Product & Services Segment Dashboard
  • 4.2. Global Bioprocess Automation Market Product & Services, Movement Analysis
  • 4.3. Global Bioprocess Automation Market Size & Trend Analysis, by Product & Services, 2021 to 2033 (USD Million)
  • 4.4. Automation Consumables & Accessories
    • 4.4.1. Global automation consumables & accessories market estimates and forecasts, 2021 - 2033 (USD Million)
  • 4.5. Process Automation Hardware
    • 4.5.1. Global Process Automation Hardware market estimates and forecasts, 2021 - 2033 (USD Million)
  • 4.6. Software & Control Systems
    • 4.6.1. Global software & control systems market estimates and forecasts, 2021 - 2033 (USD Million)
  • 4.7. Integrated & Turnkey Solutions
    • 4.7.1. Global integrated & turnkey solutions market estimates and forecasts, 2021 - 2033 (USD Million)
  • 4.8. Services & Support
    • 4.8.1. Global services & support market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 5. Process Stage Business Analysis

  • 5.1. Process Stage Segment Dashboard
  • 5.2. Global Bioprocess Automation Market Process Stage, Movement Analysis
  • 5.3. Global Bioprocess Automation Market Size & Trend Analysis, by Process Stage, 2021 to 2033 (USD Million)
  • 5.4. Upstream
    • 5.4.1. Global upstream market estimates and forecasts, 2021 - 2033 (USD Million)
  • 5.5. Downstream
    • 5.5.1. Global downstream market estimates and forecasts, 2021 - 2033 (USD Million)
  • 5.6. Process Development & Scale-up
    • 5.6.1. Global process development & scale-up market estimates and forecasts, 2021 - 2033 (USD Million)
  • 5.7. Fill/Finish & Packaging automation
    • 5.7.1. Global fill/finish & packaging automation market estimates and forecasts, 2021 - 2033 (USD Million)
  • 5.8. Quality Control & PAT
    • 5.8.1. Global quality control & PAT market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 6. End Use Business Analysis

  • 6.1. End Use Segment Dashboard
  • 6.2. Global Bioprocess Automation Market End Use, Movement Analysis
  • 6.3. Global Bioprocess Automation Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Million)
  • 6.4. Pharmaceutical & biotech manufacturers
    • 6.4.1. Global Pharmaceutical & biotech manufacturers market estimates and forecasts, 2021 - 2033 (USD Million)
  • 6.5. CDMOs & CMOs
    • 6.5.1. Global CDMOs & CMOs market estimates and forecasts, 2021 - 2033 (USD Million)
  • 6.6. Academic & research institutions
    • 6.6.1. Global academic & research institutions market estimates and forecasts, 2021 - 2033 (USD Million)
  • 6.7. Contract testing & analytical labs
    • 6.7.1. Global contract testing & analytical labs market estimates and forecasts, 2021 - 2033 (USD Million)
  • 6.8. Others
    • 6.8.1. Global others market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 7. Bioprocess Automation Market: Regional Estimates and Trend Analysis, by Product, Product & Services, End Use, & End-Use

  • 7.1. Regional Dashboard
  • 7.2. Market Size & Forecasts and Trend Analysis, 2021 to 2033
  • 7.3. North America
    • 7.3.1. North America bioprocess automation market, 2021 - 2033 (USD Million)
    • 7.3.2. U.S.
      • 7.3.2.1. Key Country Dynamics
      • 7.3.2.2. Target Disease Prevalence
      • 7.3.2.3. Competitive Scenario
      • 7.3.2.4. Regulatory Framework
      • 7.3.2.5. U.S. bioprocess automation market, 2021 - 2033 (USD Million)
    • 7.3.3. Canada
      • 7.3.3.1. Key Country Dynamics
      • 7.3.3.2. Target Disease Prevalence
      • 7.3.3.3. Competitive Scenario
      • 7.3.3.4. Regulatory Framework
      • 7.3.3.5. Canada bioprocess automation market, 2021 - 2033 (USD Million)
    • 7.3.4. Mexico
      • 7.3.4.1. Key Country Dynamics
      • 7.3.4.2. Target Disease Prevalence
      • 7.3.4.3. Competitive Scenario
      • 7.3.4.4. Regulatory Framework
      • 7.3.4.5. Mexico bioprocess automation market, 2021 - 2033 (USD Million)
  • 7.4. Europe
    • 7.4.1. Europe bioprocess automation market, 2021 - 2033 (USD Million)
    • 7.4.2. UK
      • 7.4.2.1. Key Country Dynamics
      • 7.4.2.2. Target Disease Prevalence
      • 7.4.2.3. Competitive Scenario
      • 7.4.2.4. Regulatory Framework
      • 7.4.2.5. UK bioprocess automation market, 2021 - 2033 (USD Million)
    • 7.4.3. Germany
      • 7.4.3.1. Key Country Dynamics
      • 7.4.3.2. Target Disease Prevalence
      • 7.4.3.3. Competitive Scenario
      • 7.4.3.4. Regulatory Framework
      • 7.4.3.5. Germany bioprocess automation market, 2021 - 2033 (USD Million)
    • 7.4.4. France
      • 7.4.4.1. Key Country Dynamics
      • 7.4.4.2. Target Disease Prevalence
      • 7.4.4.3. Competitive Scenario
      • 7.4.4.4. Regulatory Framework
      • 7.4.4.5. France bioprocess automation market, 2021 - 2033 (USD Million)
    • 7.4.5. Italy
      • 7.4.5.1. Key Country Dynamics
      • 7.4.5.2. Target Disease Prevalence
      • 7.4.5.3. Competitive Scenario
      • 7.4.5.4. Regulatory Framework
      • 7.4.5.5. Italy bioprocess automation market, 2021 - 2033 (USD Million)
    • 7.4.6. Spain
      • 7.4.6.1. Key Country Dynamics
      • 7.4.6.2. Target Disease Prevalence
      • 7.4.6.3. Competitive Scenario
      • 7.4.6.4. Regulatory Framework
      • 7.4.6.5. Spain bioprocess automation market, 2021 - 2033 (USD Million)
    • 7.4.7. Denmark
      • 7.4.7.1. Key Country Dynamics
      • 7.4.7.2. Target Disease Prevalence
      • 7.4.7.3. Competitive Scenario
      • 7.4.7.4. Regulatory Framework
      • 7.4.7.5. Denmark bioprocess automation market, 2021 - 2033 (USD Million)
    • 7.4.8. Sweden
      • 7.4.8.1. Key Country Dynamics
      • 7.4.8.2. Target Disease Prevalence
      • 7.4.8.3. Competitive Scenario
      • 7.4.8.4. Regulatory Framework
      • 7.4.8.5. Sweden bioprocess automation market, 2021 - 2033 (USD Million)
    • 7.4.9. Norway
      • 7.4.9.1. Key Country Dynamics
      • 7.4.9.2. Target Disease Prevalence
      • 7.4.9.3. Competitive Scenario
      • 7.4.9.4. Regulatory Framework
      • 7.4.9.5. Norway bioprocess automation market, 2021 - 2033 (USD Million)
  • 7.5. Asia Pacific
    • 7.5.1. Asia Pacific bioprocess automation market, 2021 - 2033 (USD Million)
    • 7.5.2. Japan
      • 7.5.2.1. Key Country Dynamics
      • 7.5.2.2. Target Disease Prevalence
      • 7.5.2.3. Competitive Scenario
      • 7.5.2.4. Regulatory Framework
      • 7.5.2.5. Japan bioprocess automation market, 2021 - 2033 (USD Million)
    • 7.5.3. China
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Target Disease Prevalence
      • 7.5.3.3. Competitive Scenario
      • 7.5.3.4. Regulatory Framework
      • 7.5.3.5. China bioprocess automation market, 2021 - 2033 (USD Million)
    • 7.5.4. India
      • 7.5.4.1. Key Country Dynamics
      • 7.5.4.2. Target Disease Prevalence
      • 7.5.4.3. Competitive Scenario
      • 7.5.4.4. Regulatory Framework
      • 7.5.4.5. India bioprocess automation market, 2021 - 2033 (USD Million)
    • 7.5.5. Australia
      • 7.5.5.1. Key Country Dynamics
      • 7.5.5.2. Target Disease Prevalence
      • 7.5.5.3. Competitive Scenario
      • 7.5.5.4. Regulatory Framework
      • 7.5.5.5. Australia bioprocess automation market, 2021 - 2033 (USD Million)
    • 7.5.6. Thailand
      • 7.5.6.1. Key Country Dynamics
      • 7.5.6.2. Target Disease Prevalence
      • 7.5.6.3. Competitive Scenario
      • 7.5.6.4. Regulatory Framework
      • 7.5.6.5. Thailand bioprocess automation market, 2021 - 2033 (USD Million)
    • 7.5.7. South Korea
      • 7.5.7.1. Key Country Dynamics
      • 7.5.7.2. Target Disease Prevalence
      • 7.5.7.3. Competitive Scenario
      • 7.5.7.4. Regulatory Framework
      • 7.5.7.5. South Korea bioprocess automation market, 2021 - 2033 (USD Million)
  • 7.6. Latin America
    • 7.6.1. Latin America bioprocess automation market, 2021 - 2033 (USD Million)
    • 7.6.2. Brazil
      • 7.6.2.1. Key Country Dynamics
      • 7.6.2.2. Target Disease Prevalence
      • 7.6.2.3. Competitive Scenario
      • 7.6.2.4. Regulatory Framework
      • 7.6.2.5. Brazil bioprocess automation market, 2021 - 2033 (USD Million)
    • 7.6.3. Argentina
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Target Disease Prevalence
      • 7.6.3.3. Competitive Scenario
      • 7.6.3.4. Regulatory Framework
      • 7.6.3.5. Argentina bioprocess automation market, 2021 - 2033 (USD Million)
  • 7.7. MEA
    • 7.7.1. MEA bioprocess automation market, 2021 - 2033 (USD Million)
    • 7.7.2. South Africa
      • 7.7.2.1. Key Country Dynamics
      • 7.7.2.2. Target Disease Prevalence
      • 7.7.2.3. Competitive Scenario
      • 7.7.2.4. Regulatory Framework
      • 7.7.2.5. South Africa bioprocess automation market, 2021 - 2033 (USD Million)
    • 7.7.3. Saudi Arabia
      • 7.7.3.1. Key Country Dynamics
      • 7.7.3.2. Target Disease Prevalence
      • 7.7.3.3. Competitive Scenario
      • 7.7.3.4. Regulatory Framework
      • 7.7.3.5. Saudi Arabia bioprocess automation market, 2021 - 2033 (USD Million)
    • 7.7.4. UAE
      • 7.7.4.1. Key Country Dynamics
      • 7.7.4.2. Target Disease Prevalence
      • 7.7.4.3. Competitive Scenario
      • 7.7.4.4. Regulatory Framework
      • 7.7.4.5. UAE bioprocess automation market, 2021 - 2033 (USD Million)
    • 7.7.5. Kuwait
      • 7.7.5.1. Key Country Dynamics
      • 7.7.5.2. Target Disease Prevalence
      • 7.7.5.3. Competitive Scenario
      • 7.7.5.4. Regulatory Framework
      • 7.7.5.5. Kuwait bioprocess automation market, 2021 - 2033 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Company Categorization
  • 8.2. Strategy Mapping
  • 8.3. Company Market Position Analysis, 2024
  • 8.4. Company Profiles/Listing
    • 8.4.1. Thermo Fisher Scientific Inc.
      • 8.4.1.1. Overview
      • 8.4.1.2. Financial Performance
      • 8.4.1.3. Product Benchmarking
      • 8.4.1.4. Strategic Initiatives
    • 8.4.2. Sartorius AG
      • 8.4.2.1. Overview
      • 8.4.2.2. Financial Performance
      • 8.4.2.3. Product Benchmarking
      • 8.4.2.4. Strategic Initiatives
    • 8.4.3. Parker Hannifin Corp
      • 8.4.3.1. Overview
      • 8.4.3.2. Financial Performance
      • 8.4.3.3. Product Benchmarking
      • 8.4.3.4. Strategic Initiatives
    • 8.4.4. Merck KGaA
      • 8.4.4.1. Overview
      • 8.4.4.2. Financial Performance
      • 8.4.4.3. Product Benchmarking
      • 8.4.4.4. Strategic Initiatives
    • 8.4.5. Eppendorf SE
      • 8.4.5.1. Overview
      • 8.4.5.2. Financial Performance
      • 8.4.5.3. Product Benchmarking
      • 8.4.5.4. Strategic Initiatives
    • 8.4.6. SIA Bioreactors.net
      • 8.4.6.1. Overview
      • 8.4.6.2. Product Benchmarking
      • 8.4.6.3. Strategic Initiatives
    • 8.4.7. Senieer
      • 8.4.7.1. Overview
      • 8.4.7.2. Product Benchmarking
      • 8.4.7.3. Strategic Initiatives
    • 8.4.8. Getinge
      • 8.4.8.1. Overview
      • 8.4.8.2. Financial Performance
      • 8.4.8.3. Product Benchmarking
      • 8.4.8.4. Strategic Initiatives
    • 8.4.9. Repligen Corporation
      • 8.4.9.1. Overview
      • 8.4.9.2. Financial Performance
      • 8.4.9.3. Product Benchmarking
      • 8.4.9.4. Strategic Initiatives

List of Tables

  • Table 1. List of Secondary Sources
  • Table 2. List of Abbreviations
  • Table 3. Global Bioprocess Automation Market, by Product & Services, 2021 - 2033 (USD Million)
  • Table 4. Global Bioprocess Automation Market, by Process Stage, 2021 - 2033 (USD Million)
  • Table 5. Global Bioprocess Automation Market, by End Use, 2021 - 2033 (USD Million)
  • Table 6. Global Bioprocess Automation Market, by Region, 2021 - 2033 (USD Million)
  • Table 7. North America Bioprocess Automation Market, by Country, 2021 - 2033 (USD Million)
  • Table 8. North America Bioprocess Automation Market, by Product & Services, 2021 - 2033 (USD Million)
  • Table 9. North America Bioprocess Automation Market, by Process Stage, 2021 - 2033 (USD Million)
  • Table 10. North America Bioprocess Automation Market, by End Use, 2021 - 2033 (USD Million)
  • Table 11. U.S. Bioprocess Automation Market, by Product & Services, 2021 - 2033 (USD Million)
  • Table 12. U.S. Bioprocess Automation Market, by Process Stage, 2021 - 2033 (USD Million)
  • Table 13. U.S. Bioprocess Automation Market, by End Use, 2021 - 2033 (USD Million)
  • Table 14. Canada Bioprocess Automation Market, by Product & Services, 2021 - 2033 (USD Million)
  • Table 15. Canada Bioprocess Automation Market, by Process Stage, 2021 - 2033 (USD Million)
  • Table 16. Canada Bioprocess Automation Market, by End Use, 2021 - 2033 (USD Million)
  • Table 17. Mexico Bioprocess Automation Market, by Product & Services, 2021 - 2033 (USD Million)
  • Table 18. Mexico Bioprocess Automation Market, by Process Stage, 2021 - 2033 (USD Million)
  • Table 19. Mexico Bioprocess Automation Market, by End Use, 2021 - 2033 (USD Million)
  • Table 20. Europe Bioprocess Automation Market, by Country, 2021 - 2033 (USD Million)
  • Table 21. Europe Bioprocess Automation Market, by Product & Services, 2021 - 2033 (USD Million)
  • Table 22. Europe Bioprocess Automation Market, by Process Stage, 2021 - 2033 (USD Million)
  • Table 23. Europe Bioprocess Automation Market, by End Use, 2021 - 2033 (USD Million)
  • Table 24. Germany Bioprocess Automation Market, by Product & Services, 2021 - 2033 (USD Million)
  • Table 25. Germany Bioprocess Automation Market, by Process Stage, 2021 - 2033 (USD Million)
  • Table 26. Germany Bioprocess Automation Market, by End Use, 2021 - 2033 (USD Million)
  • Table 27. UK Bioprocess Automation Market, by Product & Services, 2021 - 2033 (USD Million)
  • Table 28. UK Bioprocess Automation Market, by Process Stage, 2021 - 2033 (USD Million)
  • Table 29. UK Bioprocess Automation Market, by End Use, 2021 - 2033 (USD Million)
  • Table 30. France Bioprocess Automation Market, by Product & Services, 2021 - 2033 (USD Million)
  • Table 31. France Bioprocess Automation Market, by Process Stage, 2021 - 2033 (USD Million)
  • Table 32. France Bioprocess Automation Market, by End Use, 2021 - 2033 (USD Million)
  • Table 33. Italy Bioprocess Automation Market, by Product & Services, 2021 - 2033 (USD Million)
  • Table 34. Italy Bioprocess Automation Market, by Process Stage, 2021 - 2033 (USD Million)
  • Table 35. Italy Bioprocess Automation Market, by End Use, 2021 - 2033 (USD Million)
  • Table 36. Spain Bioprocess Automation Market, by Product & Services, 2021 - 2033 (USD Million)
  • Table 37. Spain Bioprocess Automation Market, by Process Stage, 2021 - 2033 (USD Million)
  • Table 38. Spain Bioprocess Automation Market, by End Use, 2021 - 2033 (USD Million)
  • Table 39. Denmark Bioprocess Automation Market, by Product & Services, 2021 - 2033 (USD Million)
  • Table 40. Denmark Bioprocess Automation Market, by Process Stage, 2021 - 2033 (USD Million)
  • Table 41. Denmark Bioprocess Automation Market, by End Use, 2021 - 2033 (USD Million)
  • Table 42. Norway Bioprocess Automation Market, by Product & Services, 2021 - 2033 (USD Million)
  • Table 43. Norway Bioprocess Automation Market, by Process Stage, 2021 - 2033 (USD Million)
  • Table 44. Norway Bioprocess Automation Market, by End Use, 2021 - 2033 (USD Million)
  • Table 45. Sweden Bioprocess Automation Market, by Product & Services, 2021 - 2033 (USD Million)
  • Table 46. Sweden Bioprocess Automation Market, by Process Stage, 2021 - 2033 (USD Million)
  • Table 47. Sweden Bioprocess Automation Market, by End Use, 2021 - 2033 (USD Million)
  • Table 48. Asia Pacific Bioprocess Automation Market, by Country, 2021 - 2033 (USD Million)
  • Table 49. Asia Pacific Bioprocess Automation Market, by Product & Services, 2021 - 2033 (USD Million)
  • Table 50. Asia Pacific Bioprocess Automation Market, by Process Stage, 2021 - 2033 (USD Million)
  • Table 51. Asia Pacific Bioprocess Automation Market, by End Use, 2021 - 2033 (USD Million)
  • Table 52. China Bioprocess Automation Market, by Product & Services, 2021 - 2033 (USD Million)
  • Table 53. China Bioprocess Automation Market, by Process Stage, 2021 - 2033 (USD Million)
  • Table 54. China Bioprocess Automation Market, by End Use, 2021 - 2033 (USD Million)
  • Table 55. Japan Bioprocess Automation Market, by Product & Services, 2021 - 2033 (USD Million)
  • Table 56. Japan Bioprocess Automation Market, by Process Stage, 2021 - 2033 (USD Million)
  • Table 57. Japan Bioprocess Automation Market, by End Use, 2021 - 2033 (USD Million)
  • Table 58. India Bioprocess Automation Market, by Product & Services, 2021 - 2033 (USD Million)
  • Table 59. India Bioprocess Automation Market, by Process Stage, 2021 - 2033 (USD Million)
  • Table 60. India Bioprocess Automation Market, by End Use, 2021 - 2033 (USD Million)
  • Table 61. South Korea Bioprocess Automation Market, by Product & Services, 2021 - 2033 (USD Million)
  • Table 62. South Korea Bioprocess Automation Market, by Process Stage, 2021 - 2033 (USD Million)
  • Table 63. South Korea Bioprocess Automation Market, by End Use, 2021 - 2033 (USD Million)
  • Table 64. Australia Bioprocess Automation Market, by Product & Services, 2021 - 2033 (USD Million)
  • Table 65. Australia Bioprocess Automation Market, by Process Stage, 2021 - 2033 (USD Million)
  • Table 66. Australia Bioprocess Automation Market, by End Use, 2021 - 2033 (USD Million)
  • Table 67. Thailand Bioprocess Automation Market, by Product & Services, 2021 - 2033 (USD Million)
  • Table 68. Thailand Bioprocess Automation Market, by Process Stage, 2021 - 2033 (USD Million)
  • Table 69. Thailand Bioprocess Automation Market, by End Use, 2021 - 2033 (USD Million)
  • Table 70. Latin America Bioprocess Automation Market, by Country, 2021 - 2033 (USD Million)
  • Table 71. Latin America Bioprocess Automation Market, by Product & Services, 2021 - 2033 (USD Million)
  • Table 72. Latin America Bioprocess Automation Market, by Process Stage, 2021 - 2033 (USD Million)
  • Table 73. Latin America Bioprocess Automation Market, by End Use, 2021 - 2033 (USD Million)
  • Table 74. Brazil Bioprocess Automation Market, by Product & Services, 2021 - 2033 (USD Million)
  • Table 75. Brazil Bioprocess Automation Market, by Process Stage, 2021 - 2033 (USD Million)
  • Table 76. Brazil Bioprocess Automation Market, by End Use, 2021 - 2033 (USD Million)
  • Table 77. Argentina Bioprocess Automation Market, by Product & Services, 2021 - 2033 (USD Million)
  • Table 78. Argentina Bioprocess Automation Market, by Process Stage, 2021 - 2033 (USD Million)
  • Table 79. Argentina Bioprocess Automation Market, by End Use, 2021 - 2033 (USD Million)
  • Table 80. Middle East and Africa Bioprocess Automation Market, by Country, 2021 - 2033 (USD Million)
  • Table 81. Middle East and Africa Bioprocess Automation Market, by Product & Services, 2021 - 2033 (USD Million)
  • Table 82. Middle East and Africa Bioprocess Automation Market, by Process Stage, 2021 - 2033 (USD Million)
  • Table 83. Middle East and Africa Bioprocess Automation Market, by End Use, 2021 - 2033 (USD Million)
  • Table 84. South Africa Bioprocess Automation Market, by Product & Services, 2021 - 2033 (USD Million)
  • Table 85. South Africa Bioprocess Automation Market, by Process Stage, 2021 - 2033 (USD Million)
  • Table 86. South Africa Bioprocess Automation Market, by End Use, 2021 - 2033 (USD Million)
  • Table 87. Saudi Arabia Bioprocess Automation Market, by Product & Services, 2021 - 2033 (USD Million)
  • Table 88. Saudi Arabia Bioprocess Automation Market, by Process Stage, 2021 - 2033 (USD Million)
  • Table 89. Saudi Arabia Bioprocess Automation Market, by End Use, 2021 - 2033 (USD Million)
  • Table 90. UAE Bioprocess Automation Market, by Product & Services, 2021 - 2033 (USD Million)
  • Table 91. UAE Bioprocess Automation Market, by Process Stage, 2021 - 2033 (USD Million)
  • Table 92. UAE Bioprocess Automation Market, by End Use, 2021 - 2033 (USD Million)
  • Table 93. Kuwait Bioprocess Automation Market, by Product & Services, 2021 - 2033 (USD Million)
  • Table 94. Kuwait Bioprocess Automation Market, by Process Stage, 2021 - 2033 (USD Million)
  • Table 95. Kuwait Bioprocess Automation Market, by End Use, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Bioprocess automation market segmentation
  • Fig. 2 Data analysis models
  • Fig. 3 Market formulation and validation
  • Fig. 4 Data validation & publishing
  • Fig. 5 Market research process
  • Fig. 6 Information procurement
  • Fig. 7 Primary research
  • Fig. 8 Value-chain-based sizing & forecasting
  • Fig. 9 QFD modelling for market share assessment
  • Fig. 10 Market formulation & validation
  • Fig. 11 Commodity flow analysis
  • Fig. 12 Market outlook
  • Fig. 13 Segment snapshot-1
  • Fig. 14 Competitive landscape snapshot
  • Fig. 15 Market trends & outlook
  • Fig. 16 PESTEL analysis
  • Fig. 17 Porter's five forces analysis
  • Fig. 18 Bioprocess automation market: Product & Services outlook key takeaways
  • Fig. 19 Bioprocess automation market: Product & Services movement analysis
  • Fig. 20 Automation consumables & accessories market, 2021 - 2033 (USD Million)
  • Fig. 21 Process automation hardware market, 2021 - 2033 (USD Million)
  • Fig. 22 Software & control systems market, 2021 - 2033 (USD Million)
  • Fig. 23 Integrated & turnkey solutions market, 2021 - 2033 (USD Million)
  • Fig. 24 Services & support market, 2021 - 2033 (USD Million)
  • Fig. 25 Bioprocess automation market: Process Stage outlook key takeaways
  • Fig. 26 Bioprocess automation market: Process Stage movement analysis
  • Fig. 27 Upstream market, 2021 - 2033 (USD Million)
  • Fig. 28 Downstream market, 2021 - 2033 (USD Million)
  • Fig. 29 Process development & scale-up market, 2021 - 2033 (USD Million)
  • Fig. 30 Fill/finish & packaging automation market, 2021 - 2033 (USD Million)
  • Fig. 31 Quality control & PAT market, 2021 - 2033 (USD Million)
  • Fig. 32 Bioprocess automation market: End Use outlook key takeaways
  • Fig. 33 Bioprocess automation market: End Use movement analysis
  • Fig. 34 Pharmaceutical & biotech manufacturers market, 2021 - 2033 (USD Million)
  • Fig. 35 CDMOs & CMOs market, 2021 - 2033 (USD Million)
  • Fig. 36 Academic & research institutions market, 2021 - 2033 (USD Million)
  • Fig. 37 Contract testing & analytical labs market, 2021 - 2033 (USD Million)
  • Fig. 38 Others market, 2021 - 2033 (USD Million)
  • Fig. 39 Regional marketplace outlook, 2024 & 2033 (USD Million)
  • Fig. 40 Regional marketplace: Key takeaways
  • Fig. 41 North America bioprocess automation market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 42 Key country dynamics
  • Fig. 43 U.S. bioprocess automation market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 44 Key country dynamics
  • Fig. 45 Canada bioprocess automation market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 46 Key country dynamics
  • Fig. 47 Mexico bioprocess automation market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 48 Europe bioprocess automation market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 49 Key country dynamics
  • Fig. 50 Germany bioprocess automation market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 51 Key country dynamics
  • Fig. 52 UK bioprocess automation market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 53 Key country dynamics
  • Fig. 54 France bioprocess automation market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 55 Key country dynamics
  • Fig. 56 Italy bioprocess automation market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 57 Key country dynamics
  • Fig. 58 Spain bioprocess automation market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 59 Key country dynamics
  • Fig. 60 Denmark bioprocess automation market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 61 Key country dynamics
  • Fig. 62 Sweden bioprocess automation market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 63 Key country dynamics
  • Fig. 64 Norway bioprocess automation market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 65 Asia Pacific bioprocess automation market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 66 Key country dynamics
  • Fig. 67 Japan bioprocess automation market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 68 Key country dynamics
  • Fig. 69 China bioprocess automation market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 70 Key country dynamics
  • Fig. 71 India bioprocess automation market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 72 Key country dynamics
  • Fig. 73 South Korea bioprocess automation market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 74 Key country dynamics
  • Fig. 75 Australia bioprocess automation market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 76 Key country dynamics
  • Fig. 77 Thailand bioprocess automation market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 78 Latin America bioprocess automation market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 79 Key country dynamics
  • Fig. 80 Brazil bioprocess automation market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 81 Key country dynamics
  • Fig. 82 Argentina bioprocess automation market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 83 MEA bioprocess automation market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 84 Key country dynamics
  • Fig. 85 South Africa bioprocess automation market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 86 Key country dynamics
  • Fig. 87 Saudi Arabia bioprocess automation market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 88 Key country dynamics
  • Fig. 89 UAE bioprocess automation market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 90 Key country dynamics
  • Fig. 91 Kuwait bioprocess automation market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 92 Market position analysis
  • Fig. 93 Market participant categorization
  • Fig. 94 Strategic framework